7 , 8 Aggregation of these trials indicates that in direct comparison to standard pharmacologic treatment, nonpharmacologic interventions exhibit increased relative benefit alongside only a low-moderate risk of bias, largely from issues regarding blinding and sample size, 6 , 7 , 8 illustrating an important trend regarding the relative clinical promise of nonpharmacological interventions.
← all excerpts
Endogenous neuroprotection in vascular cognitive impairment and dementia.
1
—
—